Salgia Summarizes the Benefits of Tepotinib in MET Exon 14–Mutated NSCLC

Welcome to OncLive On Air^®! I’m your host today, Ashling Wahner.

OncLive On Air is a podcast from OncLive^®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, supported by Real Chemistry, we had the pleasure of speaking with Ravi Salgia, MD, PhD, about the use of tepotinib (Tepmetko) in patients with non–small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations. Dr Salgia is a professor and chair of the Department of Medical Oncology & Therapeutics Research, as well as the Arthur & Rosalie Kaplan Chair in Medical Oncology & Therapeutics Research at City of Hope in Duarte, California.

In our exclusive interview, Dr Salgia discussed key updated findings from the phase 2 VISION trial (NCT02864992) investigating tepotinib in patients with NSCLC with MET exon 14 skipping mutations, results from a real-world analysis comparing tepotinib vs capmatinib (Tabrecta) in patients with stage IV disease, and how he chooses between these 2 agents in the clinic.

___

That’s all we have for today! Thank you for listening to this episode of OncLive On Air, supported by Real Chemistry. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.

For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.

OncLive is also on social media. On Twitter, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.

If you liked today’s episode of OncLive On Air, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!

Thanks again for listening to OncLive On Air.

*OncLive On Air is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.